Adagene Inc (ADAG)
2.58
+0.23
(+9.79%)
USD |
NASDAQ |
Apr 26, 10:16
Adagene Shareholders Equity (Quarterly): 70.56M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 70.56M |
| June 30, 2023 | 82.79M |
| December 31, 2022 | 83.09M |
| June 30, 2022 | 112.68M |
| December 31, 2021 | 156.56M |
| Date | Value |
|---|---|
| June 30, 2021 | 186.22M |
| December 31, 2020 | -89.39M |
| September 30, 2020 | 75.47M |
| December 31, 2019 | -57.01M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-89.39M
Minimum
Dec 2020
186.22M
Maximum
Jun 2021
69.00M
Average
82.79M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| China SXT Pharmaceuticals Inc | 5.076M |
| Sinovac Biotech Ltd | 8.665B |
| CASI Pharmaceuticals Inc | 24.16M |
| Zai Lab Ltd | 796.12M |
| I-MAB | 337.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.73M |
| Total Liabilities (Quarterly) | 45.17M |
| Debt to Equity Ratio | 0.3109 |
| Current Ratio | 3.606 |
| Net Debt Paydown Yield | -2.10% |